ABUS Financing Cash Flow
Arbutus Biopharma Corp · Financing Cash Flow
ABUS Financing Cash Flow
Latest reported$17.25Mperiod ending
ABUS TTM Cash from Financing ($8.15M → $17.25M)
TTM financing cash flow
High-resolution chart · PNG
ABUS financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 17,251,000 | |
| 14,556,000 | |
| 5,721,000 | |
| 5,502,000 | |
| 6,433,000 | |
| 30,350,000 | |
| 51,996,000 | |
| 54,382,000 | |
| 54,288,000 | |
| 34,660,000 | |
| 30,647,000 | |
| 37,924,000 | |
| 45,375,000 | |
| 40,746,000 | |
| 31,814,000 | |
| 79,851,000 | |
| 117,671,000 | |
| 121,847,000 | |
| 137,236,000 | |
| 98,325,000 | |
| 100,469,000 | |
| 101,139,000 | |
| 86,746,000 | |
| 80,429,000 | |
| 49,882,000 | |
| 47,402,000 | |
| 37,457,000 | |
| 23,673,000 | |
| 5,559,000 | |
| 3,815,000 | |
| 55,646,000 | |
| 104,440,000 | |
| 104,066,000 | |
| 103,335,000 | |
| 49,322,000 | |
| 12,420,000 | |
| 12,435,000 | |
| 12,877,000 | |
| 12,638,000 | |
| 612,000 | |
| 652,000 | |
| 1,166,000 | |
| 143,871,000 | |
| 144,365,000 | |
| 144,933,000 | |
| 144,207,000 | |
| 60,676,000 | |
| 92,641,219 | |
| 92,033,183 | |
| 91,866,584 | |
| 32,717,025 | |
| 942,648 | |
| 870,382 | |
| 803,276 | |
| 4,515,370 | |
| 3,927,415 | |
| 3,619,546 | |
| 8,312,651 | |
| 4,462,593 | |
| 4,394,218 | |
| 4,709,519 | |
| 36,187 | |
| 34,906 | |
| 37,171 | |
| 27,279 | |
| 7,211 | |
| 7,490 | |
| -1,227,128 | |
| -1,625,874 | |
| 8,173,079 | |
| 8,150,721 | |
| 9,392,001 | |
| 11,146,021 |